259 related articles for article (PubMed ID: 29557536)
1. Neuroendocrine Carcinomas of the Larynx and Head and Neck: Challenges in Classification and Grading.
Perez-Ordoñez B
Head Neck Pathol; 2018 Mar; 12(1):1-8. PubMed ID: 29557536
[TBL] [Abstract][Full Text] [Related]
2. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
3. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.
Gale N; Poljak M; Zidar N
Head Neck Pathol; 2017 Mar; 11(1):23-32. PubMed ID: 28247231
[TBL] [Abstract][Full Text] [Related]
4. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas.
Mills SE
Mod Pathol; 2002 Mar; 15(3):264-78. PubMed ID: 11904342
[TBL] [Abstract][Full Text] [Related]
5. Large cell neuroendocrine carcinoma of the larynx: definition of an entity.
Lewis JS; Spence DC; Chiosea S; Barnes EL; Brandwein-Gensler M; El-Mofty SK
Head Neck Pathol; 2010 Sep; 4(3):198-207. PubMed ID: 20589486
[TBL] [Abstract][Full Text] [Related]
6. Update on Neuroendocrine Carcinomas of the Larynx.
Strosberg C; Ferlito A; Triantafyllou A; Gnepp DR; Bishop JA; Hellquist H; Strojan P; Willems SM; Stenman G; Rinaldo A; Hernandez-Prera JC
Am J Clin Pathol; 2019 Nov; 152(6):686-700. PubMed ID: 31415081
[TBL] [Abstract][Full Text] [Related]
7. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
[TBL] [Abstract][Full Text] [Related]
8. Terminology and classification of neuroendocrine neoplasms of the larynx.
Lewis JS; Ferlito A; Gnepp DR; Rinaldo A; Devaney KO; Silver CE; Travis WD;
Laryngoscope; 2011 Jun; 121(6):1187-93. PubMed ID: 21557244
[TBL] [Abstract][Full Text] [Related]
9. A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells.
Chung JH; Lee SS; Shim YS; Kim SY; Nam SY; Kim DH; Cho KJ
Laryngoscope; 2004 Jul; 114(7):1264-70. PubMed ID: 15235358
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine carcinoma of the larynx.
Hartley C; Birzgalis AR; Lyons TJ; Farrington WT
J R Coll Surg Edinb; 1996 Oct; 41(5):333-5. PubMed ID: 8908962
[TBL] [Abstract][Full Text] [Related]
11. Application of INSM1 in Diagnosis and Grading of Laryngeal Neuroendocrine Carcinoma.
Yuan C; Jiao F; Zhai C; Zhang J; Wang S; Zhu L
Laryngoscope; 2021 Oct; 131(10):E2662-E2668. PubMed ID: 33847383
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine carcinomas of the larynx: what do the different histologic types really mean?
Devaney KO; Ferlito A; Rinaldo A
Eur Arch Otorhinolaryngol; 2010 Sep; 267(9):1323-5. PubMed ID: 20589504
[No Abstract] [Full Text] [Related]
13. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx.
Kasantikul V; Keelawat S; Maneesri S; Panichabhongse V
J Med Assoc Thai; 1997 Jun; 80(6):396-401. PubMed ID: 9240015
[TBL] [Abstract][Full Text] [Related]
14. [Four cases of primary neuroendocrine carcinoma in ear, nose, pharynx and larynx].
Feng Y; Xu G; Liu B; Wang H; Su X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Sep; 17(9):549-50. PubMed ID: 14658193
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies.
Hunt JL; Barnes L; Triantafyllou A; Gnepp DR; Devaney KO; Stenman G; Halmos GB; Bishop JA; Skálová A; Willems SM; Hellquist H; Rinaldo A; Ferlito A
Adv Anat Pathol; 2019 Jul; 26(4):246-250. PubMed ID: 31033507
[TBL] [Abstract][Full Text] [Related]
16. How phenotype guides management of the neuroendocrine carcinomas of the larynx.
López F; Hunt JL; Nixon IJ; Rinaldo A; Williams MD; Cardesa A; Ferlito A
J Laryngol Otol; 2018 Jul; 132(7):568-574. PubMed ID: 29909787
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification.
Huang Q; Muzitansky A; Mark EJ
Arch Pathol Lab Med; 2002 May; 126(5):545-53. PubMed ID: 11958659
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Neoplasms of the Larynx: A Clinicopathologic Analysis of 27 Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Bal M; Sharma A; Rane SU; Mittal N; Chaukar D; Prabhash K; Patil A
Head Neck Pathol; 2022 Jun; 16(2):375-387. PubMed ID: 34401980
[TBL] [Abstract][Full Text] [Related]
19. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.
van der Laan TP; Plaat BE; van der Laan BF; Halmos GB
Head Neck; 2015 May; 37(5):707-15. PubMed ID: 24596175
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine carcinoma of the head and neck: a 20-year case series.
Meacham R; Matrka L; Ozer E; Ozer HG; Wakely P; Shah M
Ear Nose Throat J; 2012 Mar; 91(3):E20-4. PubMed ID: 22430343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
